Prodopa न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

prodopa

viatris limited - methyldopa sesquihydrate 566mg equivalent to to 500 mg methyldopa anhydrous - tablet - 500 mg - active: methyldopa sesquihydrate 566mg equivalent to to 500 mg methyldopa anhydrous excipient: citric acid   colloidal silicon dioxide disodium edetate dihydrate ethylcellulose guar gum magnesium stearate opadry yellow oy-8462 purified water sodium starch glycolate - hypertension (mild, moderate or severe).

Metrogyl न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

metrogyl

viatris limited - metronidazole 200mg - tablet - 200 mg - active: metronidazole 200mg excipient: colloidal silicon dioxide disodium edetate ethylcellulose guar gum lactose monohydrate magnesium stearate sodium starch glycolate - metronidazole is indicated in the prophylaxis and treatment of infections in which anaerobic bacteria have been identified or are suspected to be the cause. metronidazole is active against a wide range of pathogenic micro-organisms notably species of bacteroides, fusobacteria, clostridia, eubacteria, anaerobic cocci and gardnerella vaginalis. it is also active against trichomonas, entamoeba histolytica, giardia lamblia and balantidium coli. metronidazole is indicated in adults and children for the following indications: 1. the prevention of postoperative infections due to anaerobic bacteria, particularly species of bacteroides and anaerobic streptococci. 2.the treatment of septicaemia, bacteraemia, peritonitis, brain abscess, necrotising pneumonia, osteomyelitis, puerperal sepsis, pelvic abscess, pelvic cellulitis, and post operative wound infections from which pathogenic anaerobes have been isolated. 3. urogenital trichomoniasis in the female (trichomonal vaginitis) and in the male. 4. bacterial vaginosis (also known as non-specific vaginitis, anaerobic vaginosis or gardnerella vaginitis). 5. all forms of amoebiasis (intestinal and extra-intestinal disease and that of symptomless cyst passers). 6. giardiasis. 7. acute ulcerative gingivitis. 8. anaerobically infected leg ulcers and pressure sores. 9. acute dental infections due to anaerobic organisms (e.g. acute pericoronitis and acute apical infections).

Metrogyl न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

metrogyl

viatris limited - metronidazole 400mg - tablet - 400 mg - active: metronidazole 400mg excipient: colloidal silicon dioxide disodium edetate ethylcellulose guar gum lactose monohydrate magnesium stearate quinoline yellow sodium starch glycolate - metronidazole is indicated in the prophylaxis and treatment of infections in which anaerobic bacteria have been identified or are suspected to be the cause. metronidazole is active against a wide range of pathogenic micro-organisms notably species of bacteroides, fusobacteria, clostridia, eubacteria, anaerobic cocci and gardnerella vaginalis. it is also active against trichomonas, entamoeba histolytica, giardia lamblia and balantidium coli. metronidazole is indicated in adults and children for the following indications: 1. the prevention of postoperative infections due to anaerobic bacteria, particularly species of bacteroides and anaerobic streptococci. 2.the treatment of septicaemia, bacteraemia, peritonitis, brain abscess, necrotising pneumonia, osteomyelitis, puerperal sepsis, pelvic abscess, pelvic cellulitis, and post operative wound infections from which pathogenic anaerobes have been isolated. 3. urogenital trichomoniasis in the female (trichomonal vaginitis) and in the male. 4. bacterial vaginosis (also known as non-specific vaginitis, anaerobic vaginosis or gardnerella vaginitis). 5. all forms of amoebiasis (intestinal and extra-intestinal disease and that of symptomless cyst passers). 6. giardiasis. 7. acute ulcerative gingivitis. 8. anaerobically infected leg ulcers and pressure sores. 9. acute dental infections due to anaerobic organisms (e.g. acute pericoronitis and acute apical infections).

Children's Claratyne न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

children's claratyne

bayer new zealand limited - loratadine 5mg (micronised);  ;   - chewable tablet - 5 mg - active: loratadine 5mg (micronised)     excipient: aspartame citric acid colloidal silicon dioxide fd & c red no. 27, aluminium lake (16-21%) c6527 grape bubblegum flavour 059145 ap0551 indigo carmine magnesium stearate mannitol microcrystalline cellulose sodium starch glycolate stearic acid - indicated for the relief of: · symptoms associated with seasonal and perennial allergic rhinitis, such as sneezing, nasal discharge and itching and ocular itching and burning. · symptoms and signs of chronic urticaria and other allergic dermatological disorders

Arrow - Tolterodine 1 न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

arrow - tolterodine 1

teva pharma (new zealand) limited - tolterodine tartrate 1mg equivalent to tolterodine 0.68 mg - film coated tablet - 1 mg - active: tolterodine tartrate 1mg equivalent to tolterodine 0.68 mg excipient: colloidal silicon dioxide magnesium stearate microcrystalline cellulose opadry white 03f58763 purified water   sodium starch glycolate - arrow – tolterodine 1 & arrow tolterodine 2 are indicated for the treatment of overactive bladder with symptoms of urinary urgency, frequency, and/or urge incontinence.

Arrow - Tolterodine 2 न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

arrow - tolterodine 2

teva pharma (new zealand) limited - tolterodine tartrate 2mg equivalent to tolterodine 1.37 mg - film coated tablet - 2 mg - active: tolterodine tartrate 2mg equivalent to tolterodine 1.37 mg excipient: colloidal silicon dioxide magnesium stearate microcrystalline cellulose opadry white 03f58763 purified water   sodium starch glycolate - arrow – tolterodine 1 & arrow tolterodine 2 are indicated for the treatment of overactive bladder with symptoms of urinary urgency, frequency, and/or urge incontinence.

Prednisone न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

prednisone

clinect nz pty limited - prednisone 1mg - tablet - 1 mg - active: prednisone 1mg excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose sodium starch glycolate - glucocorticoids are used to suppress the clinical manifestations of disease in a wide range of disorders such as: bronchial asthma, emphysema, pulmonary fibrosis, allergic skin reactions, blood disorders including auto-immune haemolytic anaemia and idiopathic thrombocytopenic purpura, selected collagen and rheumatic disorders (but rarely rheumatoid arthritis), connective tissue disorders such as arteritis and systemic lupus erythematosus, inflammatory bowel disease such as ulcerative colitis and crohn's disease, some hepatic disorders such as chronic active hepatitis, nephritic syndrome and other renal disorders, selected inflammatory ocular diseases, acute exacerbations of eczema, exfoliate dermatitis and pemphigus, and some neurological disorders such as infantile seizures (epilepsy) and sub-acute demyelinating polyneuropathy. miscellaneous uses include raised intracranial pressure, sarcoidosis, the neonatal respiratory distress syndrome, the gastric acid aspiration syndrome, acute rheumatic fever with carditis and occasionally hypercalcaemia. glucocorticoids may be used in conjunction with antineoplastic agents in regimens for the management of malignant disease such as leukaemia. they are also used to suppress the rejection phenomenon in tissue transplants.

Prednisone न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

prednisone

clinect nz pty limited - prednisone 2.5mg - tablet - 2.5 mg - active: prednisone 2.5mg excipient: lactose monohydrate magnesium stearate microcrystalline cellulose sodium starch glycolate - glucocorticoids are used to suppress the clinical manifestations of disease in a wide range of disorders such as: bronchial asthma, emphysema, pulmonary fibrosis, allergic skin reactions, blood disorders including auto-immune haemolytic anaemia and idiopathic thrombocytopenic purpura, selected collagen and rheumatic disorders (but rarely rheumatoid arthritis), connective tissue disorders such as arteritis and systemic lupus erythematosus, inflammatory bowel disease such as ulcerative colitis and crohn's disease, some hepatic disorders such as chronic active hepatitis, nephritic syndrome and other renal disorders, selected inflammatory ocular diseases, acute exacerbations of eczema, exfoliate dermatitis and pemphigus, and some neurological disorders such as infantile seizures (epilepsy) and sub-acute demyelinating polyneuropathy. miscellaneous uses include raised intracranial pressure, sarcoidosis, the neonatal respiratory distress syndrome, the gastric acid aspiration syndrome, acute rheumatic fever with carditis and occasionally hypercalcaemia. glucocorticoids may be used in conjunction with antineoplastic agents in regimens for the management of malignant disease such as leukaemia. they are also used to suppress the rejection phenomenon in tissue transplants.

Bosvate न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

bosvate

douglas pharmaceuticals limited - bisoprolol fumarate 10mg;   - tablet - 10 mg - active: bisoprolol fumarate 10mg   excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate microcrystalline cellulose sodium starch glycolate - treatment of stable chronic heart failure with reduced systolic left ventricular function in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.